← All companies

AUTL

Autolus Therapeutics plc

AUTL Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$1.82

+0.33 +22.15%

Key statistics

from XBRL data in SEC filings

Market cap

$484M

Revenue (TTM)

$92.6M

Net income (TTM)

-$289M

EPS (TTM)

$-1.09

P/E ratio

—

Dividend yield

—

Free cash flow

-$303M

Cash

$131M

Total assets

$527M

Gross margin

—

52-week range

$1.18 – $2.52

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure; Other events Aug 3, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Aug 3, 2026 8-K Shareholder vote results Jun 29, 2026 8-K Other events Jun 9, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 14, 2026 8-K Exit or disposal costs; Regulation FD disclosure Apr 29, 2026 8-K Changed accountants Apr 16, 2026 8-K Regulation FD disclosure Apr 8, 2026 10-K Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 27, 2026 8-K Entered a material agreement Jan 26, 2026 8-K Regulation FD disclosure; Other events Jan 12, 2026 8-K Director or officer change; Regulation FD disclosure Dec 2, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Nov 12, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 12, 2025 8-K Shareholder vote results Jun 27, 2025 8-K Other events Jun 2, 2025 8-K Director or officer change May 30, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 8, 2025 8-K Regulation FD disclosure Apr 23, 2025 8-K Director or officer change Apr 3, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 20, 2025 8-K Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 12, 2024 8-K Regulation FD disclosure; Other events Nov 12, 2024 8-K Regulation FD disclosure Sep 26, 2024 8-K Other events Sep 19, 2024 8-K Entered a material agreement Sep 13, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 8, 2024 8-K Shareholder vote results Jun 28, 2024 8-K Other events Jun 5, 2024 8-K Regulation FD disclosure Jun 3, 2024 10-Q Quarter ended 2024-03-31 May 17, 2024